The following constitutes the Schedule 13D filed by the undersigned (the “Schedule 13D”).
| Item 1. | Security and Issuer. |
This statement relates to shares of the Common Stock, par value $0.01 per share (the “Shares”), of Derma Sciences, Inc., a Delaware corporation (the “Issuer”). The address of the principal executive offices of the Issuer is 214 Carnegie Center, Suite 300, Princeton, New Jersey, 08540.
| Item 2. | Identity and Background. |
(a) This statement is filed by:
| | (i) | Broadfin Healthcare Master Fund, Ltd., a Cayman Islands exempted company (“Broadfin Master”); |
| | (ii) | Broadfin Healthcare Fund, L.P., a Delaware limited partnership (“Broadfin LP”), which serves as a feeder fund of Broadfin Master; |
| | (iii) | Broadfin Healthcare Offshore Fund, Ltd, a Cayman Islands exempted company (“Broadfin Offshore”), which serves as a feeder fund of Broadfin Master; |
| | (iv) | Broadfin Advisors, LLC, a Delaware limited liability company (“Broadfin Advisors”), which serves as the general partner of Broadfin LP; |
| | (v) | Broadfin Capital, LLC, a Delaware limited liability company (“Broadfin Capital”), which serves as the investment manager of each of Broadfin Master, Broadfin LP and Broadfin Offshore; and |
| | (vi) | Kevin Kotler, who serves as the managing member of each of Broadfin Capital and Broadfin Advisors. |
Each of the foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons.” Each of the Reporting Persons is party to the Joint Filing Agreement, as further described in Item 6. Accordingly, the Reporting Persons are hereby filing a joint Schedule 13D.
(b) The address of the principal office of each of Broadfin Master and Broadfin Offshore is 20 Genesis Close, Ansbacher House, Second Floor, P.O. Box 1344, Grand Cayman KY1-1108, Cayman Islands. The address of the principal office of each of Broadfin LP, Broadfin Advisors, Broadfin Capital and Mr. Kotler is 300 Park Avenue, 25th Floor, New York, New York 10022. The officers and directors of each of Broadfin Master and Broadfin Offshore and their principal occupations and business addresses are set forth on Schedule A and are incorporated by reference in this Item 2.
(c) The principal business of Broadfin Master is purchasing, holding and selling securities for investment purposes. Each of Broadfin LP and Broadfin Offshore serve as a feeder fund of Broadfin Master. The principal business of Broadfin Advisors is serving as the general partner of Broadfin LP. The principal business of Broadfin Capital is serving as the investment manager of each of Broadfin Master, Broadfin LP and Broadfin Offshore. The principal occupation of Mr. Kotler is serving as the managing member of each of Broadfin Capital and Broadfin Advisors.
(d) No Reporting Person, nor any person listed on Schedule A, annexed hereto, has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e) No Reporting Person, nor any person listed on Schedule A, annexed hereto, has during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(f) Mr. Kotler is a citizen of the United States of America. The citizenship of the persons listed on Schedule A is set forth therein.
| Item 3. | Source and Amount of Funds or Other Consideration. |
The Shares owned by Broadfin Master were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market purchases, except as otherwise noted, as set forth in Schedule B, which is incorporated by reference herein. The aggregate purchase price of the 2,130,477 Shares owned by Broadfin Master is approximately $22,455,228, excluding brokerage commissions.
| Item 4. | Purpose of Transaction. |
The Reporting Persons have recently engaged, and intend to continue to engage, in discussions with the Issuer’s management and board of directors (the “Board”) regarding the composition of the Board, generally, and means to enhance stockholder value.
The Reporting Persons purchased the Shares based on the Reporting Persons’ belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable.
No Reporting Person has any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D except as set forth herein or such as would occur upon or in connection with completion of, or following, any of the actions discussed herein. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors including, without limitation, the Issuer’s financial position and investment strategy, the price levels of the Shares, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate including, without limitation, engaging in additional communications with management and the Board of the Issuer, engaging in discussions with stockholders of the Issuer and others about the Issuer and the Reporting Persons’ investment, making proposals to the Issuer concerning changes to the capitalization, ownership structure, board structure (including board composition) or operations of the Issuer, purchasing additional Shares, selling some or all of their Shares, engaging in short selling of or any hedging or similar transaction with respect to the Shares, or changing their intention with respect to any and all matters referred to in Item 4.
| Item 5. | Interest in Securities of the Issuer. |
(a) The aggregate percentage of Shares reported owned by each person named herein is based upon 25,701,011 Shares outstanding as of March 10, 2015, which is the total number of Shares outstanding as reported in the Issuer’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 11, 2015.
As of the close of business on March 17, 2015, Broadfin Master beneficially owned 2,130,477 Shares, constituting approximately 8.3% of the Shares outstanding. Each of Broadfin LP and Broadfin Offshore, as feeder funds of Broadfin Master, may be deemed to beneficially own the 2,130,477 Shares owned by Broadfin Master, constituting approximately 8.3% of the Shares outstanding. Broadfin Advisors, as the general partner of Broadfin LP, may be deemed to beneficially own the 2,130,477 Shares owned by Broadfin Master, constituting approximately 8.3% of the Shares outstanding. Broadfin Capital, as the investment manager of Broadfin Master, may be deemed to beneficially own the 2,130,477 Shares owned by Broadfin Master, constituting approximately 8.3% of the Shares outstanding. Mr. Kotler, as the managing member of Broadfin Capital, may be deemed to beneficially own the 2,130,477 Shares owned by Broadfin Master, constituting approximately 8.3% of the Shares outstanding.
Each Reporting Person, as a member of a “group” with the other Reporting Persons for the purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, may be deemed the beneficial owner of the Shares directly owned by the other Reporting Persons. Each Reporting Person disclaims beneficial ownership of such Shares except to the extent of his or its pecuniary interest therein.
(b) By virtue of their respective positions with Broadfin Master, each of Broadfin LP, Broadfin Offshore, Broadfin Advisors, Broadfin Capital and Mr. Kotler may be deemed to have sole power to vote and dispose of the Shares reported owned by Broadfin Master.
(c) Schedule B annexed hereto lists all transaction in the Shares during the past sixty days by the Reporting Persons.
(d) No person other than the Reporting Persons is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Shares.
(e) Not applicable.
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer. |
On March 18, 2015, the Reporting Persons entered into a Joint Filing Agreement in which the Reporting Persons agreed to the joint filing on behalf of each of them of statements on Schedule 13D, with respect to securities of the Issuer, to the extent required by applicable law. A copy of this agreement is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Other than as described herein, there are no contracts, arrangements, understandings or relationships among the Reporting Persons, or between the Reporting Persons and any other person, with respect to the securities of the Issuer.
| Item 7. | Material to be Filed as Exhibits. |
| | 99.1 | Joint Filing Agreement by and among Broadfin Healthcare Master Fund, Ltd., Broadfin Healthcare Fund, L.P., Broadfin Healthcare Offshore Fund, Ltd, Broadfin Advisors, LLC, Broadfin Capital, LLC and Kevin Kotler, dated March 18, 2015. |
SIGNATURES
After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.
| Dated: March 18, 2015 | BROADFIN HEALTHCARE MASTER FUND, LTD. |
| | |
| | By: | /s/ Kevin Kotler |
| | Name: | Kevin Kotler |
| | Title: | Director |
| | BROADFIN HEALTHCARE FUND, L.P. |
| | |
| | By: | Broadfin Advisors, LLC General Partner |
| | | |
| | By: | /s/ Kevin Kotler |
| | Name: | Kevin Kotler |
| | Title: | Managing Member |
| | BROADFIN HEALTHCARE OFFSHORE FUND, LTD |
| | |
| | By: | /s/ Kevin Kotler |
| | Name: | Kevin Kotler |
| | Title: | Director |
| | BROADFIN ADVISORS, LLC |
| | |
| | By: | /s/ Kevin Kotler |
| | Name: | Kevin Kotler |
| | Title: | Managing Member |
| | BROADFIN CAPITAL, LLC |
| | |
| | By: | /s/ Kevin Kotler |
| | Name: | Kevin Kotler |
| | Title: | Managing Member |
| | |
| | /s/ Kevin Kotler |
| | KEVIN KOTLER |
SCHEDULE A
Directors and Officers of each of Broadfin Healthcare Master Fund, Ltd. and Broadfin Healthcare Offshore Fund, Ltd
| Name and Position | | Principal Occupation | | Principal Business Address | | Citizenship |
| | | | | | | |
Kevin Kotler Director* | | | | | | |
| | | | | | | |
Roger H. Hanson Director | | Managing Director of DMS Offshore Investment Services | | DMS House 20 Genesis Close P.O. Box 314 Grand Cayman KY1-1104 Cayman Islands | | Cayman Islands |
| | | | | | | |
| | Director of HighWater Limited | | HighWater Limited Grand Pavilion Commercial Centre, 1st Floor 802 West Bay Road Grand Cayman Cayman Islands | | |
*Mr. Kotler is a Reporting Person and, as such, the information with respect to Mr. Kotler called for by Item 2 of Schedule 13D is set forth therein.
SCHEDULE B
Transactions in Securities of the Issuer During the Past Sixty Days
Shares of Common Stock Purchased/(Sold) | Price Per Share($) | Date of Purchase/Sale |
BROADFIN HEALTHCARE MASTER FUND, LTD. |
| 100,000 | | 8.5000 | 02/05/2015 |
| 67,000 | | 8.9530 | 02/06/2015 |
| 28,013 | | 8.9145 | 02/09/2015 |
| 4,987 | | 8.9638 | 02/10/2015 |
| 5,000 | | 7.7244 | 03/04/2015 |
| 6,450 | | 7.7414 | 03/05/2015 |
| 10,622 | | 7.6650 | 03/06/2015 |
| 2,928 | | 7.5651 | 03/09/2015 |
| 8,600 | | 7.9859 | 03/16/2015 |
| 40,000 | | 7.9983 | 03/16/2015 |
